Primary Recipient

SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE

Amount

$119,956.00

Award Date

9/15/2009

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

Our parent R01 grant (5R01CA109345-05), which will end on June 30, 2009, proposes to investigate the molecular mechanism by which retinoid X receptor-alpha (RXR?) acts in the cytoplasm in response to 15-Deoxy-?12,14-prostaglandin J2 (15d-PGJ2) and analogs

Vendors Connected to Award

Vendor	Role	Amount
SIGMA ALDRICH INC (CA)	Primary vendor	$461.25
PERKIN ELMER LIFE AND ANALYTICAL SCIENCES	Primary vendor	$177.64
GE HEALTHCARE BIO-SCIENCES CORP	Primary vendor	$163.08
BIO-RAD LABORATORIES	Primary vendor	$470.04
FISHER SCIENTIFIC COMPANY LLC	Primary vendor	$1,050.46
SANTA CRUZ BIOTECHNOLOGY INC	Primary vendor	$127.81
CAYMAN CHEMICAL CO INC	Primary vendor	$90.38
CELL SIGNALING TECHNOLOGY	Primary vendor	$446.48
DHARMACON INC	Primary vendor	$730.79
NEW ENGLAND BIOLABS	Primary vendor	$92.44
VWR INTERNATIONAL INC	Primary vendor	$653.10
ECHELON BIOSCIENCES INC	Primary vendor	$553.20